Gilead Sciences | ARS: Annual Report to Security Holders
Gilead Sciences | DEF 14A: Definitive information statements
Gilead Sciences | DEFA14A: Others
Gilead Sciences | 8-K: Gilead Sciences Announces Completion of Acquisition of CymaBay Therapeutics and Enters into an Agreement and Plan of Merger with Wholly-Owned Subsidiary Pacific Merger Sub
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Gilead Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Gilead Sciences | 8-K: Kevin E. Lofton Will Retire from the Board
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Telman Deborah H
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Patterson Sandra
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Parsey Merdad
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer O'Day Daniel Patrick
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Mercier Johanna
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Dickinson Andrew D
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Parsey Merdad
Gilead Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Gilead Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data